Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Workman

Showing results (41-50 of 315) with videos related to

Pageof 32
Sort By:
Nature Medicine|December 8, 2007
Putting the heat on cancerPaul Workman, Emmanuel de Billy
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 8, 2005
Genomic profiling of cancer: what next?Paul Workman, Patrick G Johnston
Cancer Discovery|June 4, 2014
EML4-ALK fusions: propelling cancer but creating exploitable chaperone dependencePaul Workman, Rob van Montfort
Nature|October 19, 2012
Molecular biology: Choose your protein partnersRahul S Samant, Paul Workman
Endocrine-Related Cancer|January 30, 2007
Targeting of multiple signalling pathways by heat shock protein 90 molecular chaperone inhibitorsMarissa V Powers, Paul Workman
Nature Chemical Biology|July 20, 2007
Chaperoning cell death: a critical dual role for Hsp90 in small-cell lung cancerPaul Workman, Marissa V Powers
Future Medicinal Chemistry|September 2, 2016
Minimizing bias in target selection by exploiting multidisciplinary Big Data and the protein interactomeBissan Al-Lazikani, Paul Workman
Cell Cycle (Georgetown, Tex.)|January 30, 2009
Targeting CDC37: an alternative, kinase-directed strategy for disruption of oncogenic chaperoningJennifer R Smith, Paul Workman
Oncotarget|April 26, 2011
A stressful life (or death): combinatorial proteotoxic approaches to cancer-selective therapeutic vulnerabilityPaul Workman, Faith E Davies
Cancer Cell|April 13, 2011
Resisting targeted therapy: fifty ways to leave your EGFRPaul Workman, Paul A Clarke
Pageof 32

Showing results (41-50 of 315) with videos related to

Sort By:
Pageof 32
Nature Medicine|December 8, 2007
Putting the heat on cancerPaul Workman, Emmanuel de Billy
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 8, 2005
Genomic profiling of cancer: what next?Paul Workman, Patrick G Johnston
Cancer Discovery|June 4, 2014
EML4-ALK fusions: propelling cancer but creating exploitable chaperone dependencePaul Workman, Rob van Montfort
Nature|October 19, 2012
Molecular biology: Choose your protein partnersRahul S Samant, Paul Workman
Endocrine-Related Cancer|January 30, 2007
Targeting of multiple signalling pathways by heat shock protein 90 molecular chaperone inhibitorsMarissa V Powers, Paul Workman
Nature Chemical Biology|July 20, 2007
Chaperoning cell death: a critical dual role for Hsp90 in small-cell lung cancerPaul Workman, Marissa V Powers
Future Medicinal Chemistry|September 2, 2016
Minimizing bias in target selection by exploiting multidisciplinary Big Data and the protein interactomeBissan Al-Lazikani, Paul Workman
Cell Cycle (Georgetown, Tex.)|January 30, 2009
Targeting CDC37: an alternative, kinase-directed strategy for disruption of oncogenic chaperoningJennifer R Smith, Paul Workman
Oncotarget|April 26, 2011
A stressful life (or death): combinatorial proteotoxic approaches to cancer-selective therapeutic vulnerabilityPaul Workman, Faith E Davies
Cancer Cell|April 13, 2011
Resisting targeted therapy: fifty ways to leave your EGFRPaul Workman, Paul A Clarke
Pageof 32